182 related articles for article (PubMed ID: 38594692)
1. SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights.
Geng R; Zhao Y; Xu W; Ma X; Jiang Y; Han X; Zhao L; Li Y
J Transl Med; 2024 Apr; 22(1):338. PubMed ID: 38594692
[TBL] [Abstract][Full Text] [Related]
2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
3. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
4. Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
Zhao T; Zeng J; Xu Y; Su Z; Chong Y; Ling T; Xu H; Shi H; Zhu M; Mo Q; Huang X; Li Y; Zhang X; Ni H; You Q
Theranostics; 2022; 12(16):6989-7008. PubMed ID: 36276655
[No Abstract] [Full Text] [Related]
5. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
[TBL] [Abstract][Full Text] [Related]
6. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.
Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y
Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549
[TBL] [Abstract][Full Text] [Related]
7. The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma.
Han X; Yan Z; Fan K; Guan X; Hu B; Li X; Ou Y; Cui B; An L; Zhang Y; Gong J
Front Immunol; 2023; 14():1220100. PubMed ID: 37662954
[TBL] [Abstract][Full Text] [Related]
8. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
9. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
[No Abstract] [Full Text] [Related]
10. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
11. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
[TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
[TBL] [Abstract][Full Text] [Related]
13. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
Front Immunol; 2021; 12():628966. PubMed ID: 33664747
[TBL] [Abstract][Full Text] [Related]
14. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
16. Development of a prognostic index based on immunogenomic landscape analysis in glioma.
Luo H; Tao C; Wang P; Li J; Huang K; Zhu X
Immun Inflamm Dis; 2021 Jun; 9(2):467-479. PubMed ID: 33503296
[TBL] [Abstract][Full Text] [Related]
17. Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing.
Zhang X; Tan J; Zhang X; Pandey K; Zhong Y; Wu G; He K
Math Biosci Eng; 2024 Jan; 21(2):2407-2431. PubMed ID: 38454689
[TBL] [Abstract][Full Text] [Related]
18. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
Li J; Zhang Y; Qu Z; Ding R; Yin X
Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
[TBL] [Abstract][Full Text] [Related]
19. HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma.
Xu S; Xiao H; Song T; Zeng Y; Wei C; Chen T; Hu Z; Guo R; Li D; Jiang M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14911-14926. PubMed ID: 37603105
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment
Zha C; Meng X; Li L; Mi S; Qian D; Li Z; Wu P; Hu S; Zhao S; Cai J; Liu Y
Cancer Biol Med; 2020 Feb; 17(1):154-168. PubMed ID: 32296583
[No Abstract] [Full Text] [Related]
[Next] [New Search]